HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

agnuside

isolated from Vitex peduncularis; structure in first source

Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycosides: 2119
  - Glucosides: 639
    - agnuside: 4

Experts

1.	Bhardwaj, Neha: 1 article (05/2022)
2.	Sharma, Anamika: 1 article (05/2022)
3.	Tirpude, Narendra Vijay: 1 article (05/2022)
4.	Boadi, Evans Owusu: 1 article (10/2021)
5.	Chang, Yan-Xu: 1 article (10/2021)
6.	Chen, Xuanhao: 1 article (10/2021)
7.	Fang, Shiming: 1 article (10/2021)
8.	Gao, Xiu-Mei: 1 article (10/2021)
9.	He, Jun: 1 article (10/2021)
10.	Li, Jin: 1 article (10/2021)

Related Diseases

1.	Fibrosis (Cirrhosis) 05/01/2022 - "Results revealed that agnuside showed prophylactic effect in assuaging asthmatic lung architecture impairment (p ≤ 0.01) as indicated by suppression of inflammatory cell infiltration, congestion, fibrosis, airway remodeling and alveolar collapse in OVA-LPS sensitized group. " 05/01/2022 - "Agnuside mitigates OVA-LPS induced perturbed lung homeostasis via modulating inflammatory, autophagy, apoptosis-fibrosis response and myeloid lineages in mice model of allergic asthma." 05/01/2022 - "Present study aimed to assess efficacy of agnuside in targeting vicious circle of oxi-inflammation, autophagy and fibrosis, together with investigating its underlying molecular mechanism during OVA-LPS induced allergic asthma. " 01/01/2021 - "Agnuside Alleviates Synovitis and Fibrosis in Knee Osteoarthritis through the Inhibition of HIF-1α and NLRP3 Inflammasome."
2.	Inflammation (Inflammations) 05/01/2022 - "Present study aimed to assess efficacy of agnuside in targeting vicious circle of oxi-inflammation, autophagy and fibrosis, together with investigating its underlying molecular mechanism during OVA-LPS induced allergic asthma. "
3.	Asthma (Bronchial Asthma) 05/01/2022 - "Collectively, these outcomes confer prophylactic attribute of agnuside and signify it as promising strategy to thwart allergic asthma." 05/01/2022 - "Suppression in myeloid cells activation and augmentation (p ≤ 0.001) of Tregs established modulatory attribute of agnuside for innate and adaptive immune response during allergic asthma. " 05/01/2022 - "Agnuside mitigates OVA-LPS induced perturbed lung homeostasis via modulating inflammatory, autophagy, apoptosis-fibrosis response and myeloid lineages in mice model of allergic asthma." 05/01/2022 - "Present study aimed to assess efficacy of agnuside in targeting vicious circle of oxi-inflammation, autophagy and fibrosis, together with investigating its underlying molecular mechanism during OVA-LPS induced allergic asthma. "
4.	Airway Remodeling 05/01/2022 - "Results revealed that agnuside showed prophylactic effect in assuaging asthmatic lung architecture impairment (p ≤ 0.01) as indicated by suppression of inflammatory cell infiltration, congestion, fibrosis, airway remodeling and alveolar collapse in OVA-LPS sensitized group. "
5.	Knee Osteoarthritis 01/01/2021 - "Agnuside Alleviates Synovitis and Fibrosis in Knee Osteoarthritis through the Inhibition of HIF-1α and NLRP3 Inflammasome."

Related Drugs and Biologics

1.	Inflammasomes
2.	Luteolin
3.	casticin